Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

New proposals published today by MRC HIU suggest that iron supplements on their own are not enough to efficiently tackle this disease.

Anaemia affects 273 million children and 529 million women globally, accounting for 8.8% of all years lived with disability. Anaemia prevalence in children under-5 years is highest in sub-Saharan Africa (62.3%) and South-East Asia (53.8%). Iron is an essential micronutrient required for many biological processes, and iron deficiency can compromise diverse physiological functions and commonly leads to anaemia. It is therefore unsurprising that until now, public health strategies to control anaemia emphasised iron replenishment, and focused on strategies such as food fortification with iron and universal distribution of iron supplements. However, the prevalence of anaemia across the developing world has not markedly improved despite decades of iron-focussed nutritional programmes. This failure to resolve the anaemia burden has frequently been attributed to programmatic limitations, such as financing, supply, distribution or adherence to interventions.

“The mechanistic work we do in the lab, and our collaborations with MRC Gambia, have shown at a molecular level how infections and inflammation prevent absorption of dietary iron. This has given us some insight into why anaemia rates across the developing world have been persistently very high for so long despite huge efforts by aid agencies. Unless we emphasize the fight against infection, we fear anaemia will continue to be a huge global health problem. - Prof Hal Drakesmith

In his latest paper, published in the The BMJ, Prof Hal Drakesmith at the MRC Human Immunology Unit (Radcliffe Department of Medicine) and collaborators in Australia and MRC Gambia provide a cross-disciplinary synthesis of data from fields of infection, haematology, nutrition and global health to address the problem of anaemia. Their analysis showed that in countries where there is a high infection burden, for example from malaria or intestinal pathogens, providing iron supplements may increase patient susceptibility to infection, and often does not improve anaemia. This is particularly important because the majority of young children affected by anaemia live in sub-Saharan Africa and Asia, areas endemic to many of these infections.

Their analysis concludes with a series of proposals for changes to the World Health Organisation recommendations, and for new research agendas. This work was funded by the Medical Research Council and the Haematology Theme, NIHR Oxford Biomedical Research Centre.

 

 

Similar stories

New study reveals role of lymphatic system in bone healing

It was previously assumed that bones lacked lymphatic vessels, but new research from the MRC Human Immunology Unit at Oxford's MRC Weatherall Institute for Molecular Medicine not only locates them within bone tissue, but demonstrates their role in bone and blood cell regeneration and reveals changes associated with aging.

Understanding the interplay of dietary iron, anaemia and the immune system

Four related projects aim to unravel how the iron we eat shapes how the immune system develops and responds to vaccines.

How HIV acquires its lipid membrane shell

The Eggeling group used super-resolution microscopy to show that HIV-1 creates its own specialized lipid membrane environment for virus assembly.

Immune response explained by mathematics of narrow escapes

Study finds that shape of immune cells plays key role in recognising invaders.

Single cell analysis paves the way for better treatments for IBD

Researchers at MRC HIU examined the large intestine using sophisticated single cell technology, in work that paves the way for better treatments for IBD.

New research makes progress towards general Salmonella vaccine

Work by researchers at MRC HIU zeroes in on the mechanisms by which T cells respond to Salmonella infections.